Selection of ligands for polyclonal antibodies from random peptide libraries: Potential identification of (auto)antigens that may trigger B and T cell responses in autoimmune diseases

Clinical Immunology and Immunopathology

Volumn 79, Issue 2, 1996, Pages 105-114

  Sioud, Mouldy ^a   Førre, Øystein ^a   Dybwad, Anne ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; LIGAND; POLYCLONAL ANTIBODY; VACCINE;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; ETIOLOGY; HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029935611     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0057     Document Type: Review

References (65)

1. Smith, G. P., Filamentousfusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315-1316, 1985.
2. Scott, J. K., and Craig, L., Random peptide libraries. Curr. Opin. Biotechnol. 5, 40-48, 1994.
3. Stephen, C. W., and Lane, D. P., Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library. J. Mol. Biol. 225, 577-583, 1992.
4. Blond-Elguindi, S., Cwirla, S. E., Dower, W. J., Lipshutz, R. J., Sprang, S. R., Sambrook, J. F., and Gething, M.-J. H., Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP. Cell 75, 717-728, 1993.
5. Cull, M. G., Miller, J. F., and Schatz, P. J., Screening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor. Proc. Natl. Acad. Sci. USA 89, 1865-1869 1992.
6. Lam, K. S., Salmon, S. E., Hersh, E. M., Hruby, V. J., Kazmierski, W. M., and Knapp, R. J., A new type of synthetic peptide library for identifying ligand-binding activity. Nature 354, 82-84, 1991.
7. Houghten, R. A., Pinilla, C., Blondelle, S. E., Appel, J. R., Dooley, C. T., and Cuervo, J. H., Generation and use of synthetic peptide combinatorial libraries for basic research and drug discobery. Nature 354, 84-86, 1991.
8. Scott, J. K., and Smith, G. P., Searching for peptide ligands with an epitope library. Science 249, 386-390, 1990.
9. Cwirla, S. E., Peters, E. A., Barrett, R. W., and Dower, W. J., Peptides on phage: A vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. USA 87, 6378-6382, 1990.
10. Greenwood, J., Willis, A. E., and Perham, R. N., Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens. J. Md. Biol. 220, 821-827, 1991.
11. Felici, F., Castagnoli, L., Musacchio, A., Jappelli, R., and Cesareni, G., Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J. Mol. Biol. 222, 301-310, 1991.
12. Christian, R. B., Zuckermann, R. N., Kerr, J. M., Wang, L., and Malcolm, B. A., Simplified methods for construction, assessment and rapid screening of peptidelibraries in bacteriophage. J. Mol. Biol. 227, 711-718, 1992.
13. Dybwad, A., Bogen, B., Natvig, J. B., Førre, Ø., and Sioud, M., Peptide phage libraries can be an efficient tool for identifying antibody ligands for polyclonal antisera. Clin. Exp. Immunol. 102, 438-442, 1995.
14. Dybwad, A., Førre, Ø., Natvig, J. B., and Sioud, M., Structural characterization of peptides that bind synovial fluid antibodies from RA patients: A novel strategy for identification of disease-related epitopes using a random peptide library. Clin. Immunol. Immunopathol. 75, 45-50, 1995.
15. Jellis, C. L., Cradick, T. J, Rennert, P., Salinas, P., Boyd, J., Amirault, T., and Gray, G. S., Defining critical residues in the epitope for a HIV-neutralizing monoclonal antibody using phage display and peptide array technologies. Gene 137, 63-68, 1993.
16. Parmley, S. F., and Smith, G. P., Antibody-selectable filamentous fd phage vectors: Affinity purification of target genes. Gene 73, 305-318, 1988.
17. Oldenburg, K. R., Loganathan, D., Goldstein, I. J., Schultz, P. G., and Gallop, M. A., Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc. Natl. Acad. Sci. USA 89, 5393-5397, 1992.
18. O'Neil, K. T., Hoess, R. H., Jackson, S. A., Ramachandran, N. S., Mousa, S. A., and DeGrado, W. F., Identification of novel peptide antagonists for GPII/IIIa from a conformationallu constrained phage peptide library. Proteins 14, 509-515, 1992.
19. Sinigaglia, F., and Hammer, J., Defining rules for the peptide-MHC class II interaction. Curr. Opin. Immunol. 6, 52-56, 1994.
20. Dybwad, A, Førre, Ø., Kjeldsen-Kragh, J., Natvig, J. B., and Sioud, M., Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library. Eur. J. Immunol. 23, 3189-3193, 1993.
21. Alspaugh, M. A., Henle, G., Lennette, E. T., and Henle, W., Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J. Clin. Invest. 67, 1134-1140, 1981.
22. Østenstad, B., Dybwad, A., Lea, T., Førre, Ø., Vinje, O., and Sioud, M., Evidence for monoclonal expansion of synovial T cells bearing Vα2.1/Vβ5 5 gene segments and recognizing a synthetic peptide that shares a homdogy with a number of putative autoantigens. Immunology 86, 168-175, 1995.
23. Lanchbury, J. S., The HLA association with rgeumatoid arthritis. Clin. Exp. Rheumol. 10, 301-304, 1992.
24. Ebringer, A., Cunningham, P., Ahmadi, K., Wrigglesworth, J., Hosseini, R., and Wilson, C., Sequence similarity between HLA-DR1 and DR4 subtypes associated with rheumatoid arthritis and Proteus/Serrratia membrane haemolysins. Ann. Rheum. Dis. 51, 1245-1246, 1992.
25. Wilson, C., Ebringer, A., Agmadi, K., Wrigglesworth, J., Tiwana, H., Fielder, M., Binder, A., Ettelaie, C., Cunningham, P., Joannon, C., and Bansal, S., Shared aminoacid sequences between MHC class II glycoproteins, Type XI Collagen and Proteus mirabilis in rheumatoid arthritis. Ann. Rheum. Dis. 54, 216-220, 1995.
26. Roudier, J., Petersen, J., Rhodes, G. H., Luka, J., and Carson, D. A., Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DRβ-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc. Natl. Acad. Sci. USA 86, 5104-5108, 1989.
27. Balass, M., Heldmann, Y., Cabilly, S., Givol, D., Katchalski-Katzir, E., and Fuchs, S., Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library. Proc. Natl. Acad. Sci. USA 90, 10638-10642, 1993.
28. Hoess, R. H., Mack, A. J., Walton, H., and Reilly, T. M., Identification of a structural epitope by using a peptidelibrary displayed on filamentous bacteriophage. J. Immunol. 153, 724-729, 1994.
29. Broome, S., and Gilbert, W., Hormone phage: An enrichment method for variant proteins with altered binding properties. Proteins 8, 309-314, 1990.
30. Young, R. A., and Davis, R. W., Efficient isolation of genes using antibody probes. Proc. Natl. Acad. Sci. USA 80, 1194-1198, 1983.
31. Wood, W. I., Gitschier, J., Lasky, L. A., and Lawn, R. M., Base composition-independent hybridization in tetranetyl ammonium chloride: A method of oligonucleotide screening of highly complex gene libraries. Proc. Natl. Acad. Sci. USA 82, 1585-1588, 1985.
32. Smiley, J. D., Sachs, C., and Ziff, M., In vitro synthesis of immunolobulin by rheumatoid synovial membrane. J. Clin. Invest. 47, 624-632, 1968.
33. Panush, R. S., Bianco, N. E., and Schur, P. H., Serum and synovial fluid IgG, I gA, and I gM antigammaglobulins in rheumatoid arthritis. Arthritis Rheum. 14, 737-747, 1971.
34. Lafyatis, R., Flipo, R. M., Duquesnoy, B., and Capron, A., Antibodies in rheumatoid synovial fluids bind to a restricted series of protein antigens in rheumatoid synovila tissue. Arthrites Rheum. 35, 1016-1027, 1992.
35. Worthington, J., Turner, S., Brass, A., and Morgan, K., Epitopes on the CB-11 peptide of type II collagen recognized by antibodies from patients with rheumatoid arthritis. Br. J. Rheumol. 32, 658-662, 1993.
36. Tan, E. M., Autoimmunity and apoptosis. J. Exp. Med. 179, 1083-1086, 1994.
37. Silverman, G. J., Carson, D. A., Patrick, K., Vaughan, J. H., and Fong, S, Expression of a germline human kappa chain-associated cross-reactive idiotype after in vitro and in vivo infection with Epstein-Barr virus. Clin. Immunol. Immunopathol. 43, 403-411, 1987.
38. Morgan, K., Clague, R. B., Collins, I., Ayad, S., Phinn, S. D., and Holt, P. J. L., Incidence of antibodiesto native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis. Ann. Rheum. Dis 46, 902-907, 1987.
39. + B lymphocytes. Ann. Rev. Immunol. 7, 513-535, 1989.
40. Lee, S. K., Bridges, S. L. Kirkham, P. M., Koopman, W. J., and Schroeder, H. W., Evidence of antigen receptor-influenced oliglonal B lymphocyte expansion in the synovium of a patient with longstanding rheumatoid arthritis. J. Clin. Invest. 93, 361-370, 1994.
41. Nardella, F. A., Teller, D. C., Barber, C. V., and Mannik, M., IgG rheumatoid factors and staphylococcal protein A bind to a common molecular site on IgG. J. Exp. Med. 162, 1811-1824, 1985.
42. Artandi, S. E., Calame, K. L., Morrison, S. L., and Bonagura, V. R., Monoclonal IgM rheumatoid factors bind IgG at a discontinuous epitope comprised of amino acid loops from heavy-chain constant-region domains 2 and 3. Proc. Natl. Acad. Sci. USA 89, 94-98, 1992.
43. Peter, J. B. (Ed.), "Use and Interpretation of Tests in Clinical Immunology," Specialty Laboratories, Inc., Santa Monica, CA, 1991.
44. Reichlin, M., Antibodies to ribonuclear proteins. In "Systemic Lupus Erythematosus"(B. Dudlick, Ed.), pp. 29-43, Rheum. Dis. Clin. N. Am., Saunders, Philadelphia, 1994.
45. Davidoff, A. M., Iglehart, J. D., and Marks, J. R., Immune response to p531 s dependent upon p53/HSP70 complex exes breast cancers. Proc. Natl. Acad. Sci. USA 89, 3439-3442, 1992.
46. Winter, S. F., Minna, J. D., Johnson, B. E., Takahashi, T , Gazdar, A. F., and Carbone, D. P., Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res. 52, 4168-4174, 1992.
47. Fomsgaard, A., Svenson, M., and Benutzen, K., Auto-antibodies to tumour necrosis factor alpha in healthy humans and patients with inflammatory diseases and Gram-negative bacterial infections. Scand. J. Immunol. 30, 219-223, 1989.
48. Bogen, B., and Lambris, J. D., Minimum length of an idiotypic peptide and a model for its binding to a major hist compatibility complex class II molecule. EMBO. J. 8, 1947-1952, 1989.
49. Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., and Kollias, G., Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J. 10, 4025-4031, 1991.
50. Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., and Woody, J. N., Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosos factor α. Arthritis Rheum. 36, 1681-1690, 1993.
51. Sioud, M., Dybwad, A., Jespersen, L., Suleyman, S., Natvig, J. B., and Førre, Ø., Characterization of naturally occurning autoantibodies against tumour necrosis factor-alph a (TNF-α) In vitro function and precise epitope mapping by phage epitope library. Clin. Exp. Immunol. 98, 520-525, 1994.
52. Pennicia, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggerwal, B. B., and Goeddel, D. V., Human tumour nectosis factor: Precursor strcture, expression and homology to lymphotooxin. Nature 312, 724-729, 1984.
53. Kay, B. K., Adey, N. B., He, Y.-S., Manfredi, J. P., Mataragnon, A. H., and Fowlkes, D. M., An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to selected targets. Gene 128, 59-65, 1993.
54. Folgori, A., Tafi, R., Meola, A., Felici, F., Galfre, G., Cortese, R., Monaci, P., and Nicosia, A., A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J. 13, 2236-2243, 1994.
55. Dela Cruz, V. F., Lal, A. A., and McCutchan, T. F., Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage. J. Biol. Chem. 263, 4318-4322, 1988.
56. Keller, P. M., Arnold, B. A., Shaw, A. R., Tolman, R. L., Van Middlesworth, F., Bondy, S., Rusiecki, V. K., Koenig, S., ZollaPazner, S., Conrad, P., Emini, E. A., and Conley, A. J., Identification of HIV vaccine candidate peptides by screening random phage epitope libraries. Virology 193, 709-716, 1993.
57. Fehci, F., Luzzago, A., Folgori, A., and Cortese, R., Mimicking of discontinuous epitopes by phage-displayed peptides. II. Selection of clones recognized by a protective monoclonal antibody against the Bordetella pertussis toxin from phage peptide libraries. Gene 128, 21-27, 1993.
58. Kabsch, W., and Sander, C., On the use of sequence homologies to predict protein structure Identical pentapeptides can have completely different conformations. Proc. Natl. Acad. Sci. USA 81, 1075-1078, 1984.
59. Kotb, M., Infection and autoimmumty: A story of the host, the pathogen, and the copathogen. Clin, Immunol. Immunopathol. 74, 10-22, 1995.
60. Van der Zee, R., Van Eden, W., Meloen, R.H., Noordzij, A., and Van Embden, J. D. A., Efficiant mapping and characterization of a T cell epitope by the simultaneous synthesis of multiple peptides. Eur. J. Immunol. 19, 43-47, 1989.
61. Smith, S. C., and Allen, P. M., Myosin-induced acute myocar ditis is a T cell-mediated disease. J. Immunol. 147, 2141-2147, 1991.
62. Hickling, J. K., Jones, K. R., Yuan, B., Rothbard, J. B., and Bulow, R., A method for rapid screening of recombinant proteins for recognition by T lymphocytes. Eur. J. Immunol. 22, 1983-1987, 1992.
63. O'Mahony, S., and Ferguson, A., Small intestinal mucosal protection mechanisms and their importance in rheumatology. Ann. Rheum. Dis. 50, 331-336, 1991.
64. Bottger, V., and Lane, E. B., A monoclonal antibody epitope on keratin 8 identified using a phage peptide library. J. Mol. Biol. 235, 61-67, 1994.
65. Hoess, R. H., Brinkmann, U., Handel, T., and Pastan, I., Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3. Gene 128, 43-49, 1993.